These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 14673954

  • 1. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
    Udayakumar TS, Nagle RB, Bowden GT.
    Prostate; 2004 Jan 01; 58(1):66-75. PubMed ID: 14673954
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression.
    Udayakumar TS, Bair EL, Nagle RB, Bowden GT.
    Mol Carcinog; 2003 Oct 01; 38(2):70-7. PubMed ID: 14502646
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines.
    Stearns ME, Wang M, Hu Y, Garcia FU, Rhim J.
    Clin Cancer Res; 2003 Mar 01; 9(3):1191-9. PubMed ID: 12631625
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3.
    Udayakumar TS, Stratton MS, Nagle RB, Bowden GT.
    Neoplasia; 2002 Mar 01; 4(1):60-7. PubMed ID: 11922392
    [Abstract] [Full Text] [Related]

  • 5. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells.
    Polette M, Gilles C, Nawrocki-Raby B, Lohi J, Hunziker W, Foidart JM, Birembaut P.
    Cancer Res; 2005 Sep 01; 65(17):7691-8. PubMed ID: 16140936
    [Abstract] [Full Text] [Related]

  • 6. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
    Sanford DC, DeWille JW.
    Prostate; 2005 May 01; 63(2):143-54. PubMed ID: 15486993
    [Abstract] [Full Text] [Related]

  • 7. Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer.
    Giri D, Ropiquet F, Ittmann M.
    Clin Cancer Res; 1999 May 01; 5(5):1063-71. PubMed ID: 10353739
    [Abstract] [Full Text] [Related]

  • 8. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C, Polette M, Seiki M, Birembaut P, Thompson EW.
    Lab Invest; 1997 May 01; 76(5):651-60. PubMed ID: 9166284
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts.
    Sato T, Iwai M, Sakai T, Sato H, Seiki M, Mori Y, Ito A.
    Br J Cancer; 1999 Jun 01; 80(8):1137-43. PubMed ID: 10376963
    [Abstract] [Full Text] [Related]

  • 10. [Inhibitory effect of MT1-MMP antisense nucleotide on invasion of human highly metastatic ovarian cancer cell line SW626].
    Wu MF, Liao GN, Jia P, Xi L, Lu YP, Ma D.
    Ai Zheng; 2004 Nov 01; 23(11):1263-6. PubMed ID: 15522170
    [Abstract] [Full Text] [Related]

  • 11. Both autocrine and paracrine effects of transfected acidic fibroblast growth factor are involved in the estrogen-independent and antiestrogen-resistant growth of MCF-7 breast cancer cells.
    Zhang L, Kharbanda S, Hanfelt J, Kern FG.
    Cancer Res; 1998 Jan 15; 58(2):352-61. PubMed ID: 9443417
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of a secretory form of FGF-1 promotes MMP-1-mediated endothelial cell migration.
    Partridge CR, Hawker JR, Forough R.
    J Cell Biochem; 2000 Jun 06; 78(3):487-99. PubMed ID: 10861846
    [Abstract] [Full Text] [Related]

  • 13. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
    Ottino P, He J, Axelrad TW, Bazan HE.
    Invest Ophthalmol Vis Sci; 2005 Feb 06; 46(2):487-96. PubMed ID: 15671273
    [Abstract] [Full Text] [Related]

  • 14. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
    Upadhyay J, Shekarriz B, Nemeth JA, Dong Z, Cummings GD, Fridman R, Sakr W, Grignon DJ, Cher ML.
    Clin Cancer Res; 1999 Dec 06; 5(12):4105-10. PubMed ID: 10632347
    [Abstract] [Full Text] [Related]

  • 15. The role of fibroblast growth factors and their receptors in prostate cancer.
    Kwabi-Addo B, Ozen M, Ittmann M.
    Endocr Relat Cancer; 2004 Dec 06; 11(4):709-24. PubMed ID: 15613447
    [Abstract] [Full Text] [Related]

  • 16. Rapid tumor development and potent vascularization are independent events in carcinoma producing FGF-1 or FGF-2.
    Billottet C, Janji B, Thiery JP, Jouanneau J.
    Oncogene; 2002 Nov 21; 21(53):8128-39. PubMed ID: 12444548
    [Abstract] [Full Text] [Related]

  • 17. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
    Shain SA.
    Mol Cancer Res; 2004 Nov 21; 2(11):653-61. PubMed ID: 15561781
    [Abstract] [Full Text] [Related]

  • 18. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF, Wang Y, Cho JY, Libermann TA.
    Cancer Res; 2003 May 01; 63(9):2206-15. PubMed ID: 12727841
    [Abstract] [Full Text] [Related]

  • 19. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
    Cardillo MR, Di Silverio F, Gentile V.
    Anticancer Res; 2006 May 01; 26(2A):973-82. PubMed ID: 16619495
    [Abstract] [Full Text] [Related]

  • 20. E1AF expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of MT1-MMP gene promoters.
    Izumiyama Y, Ohiro Y, Higashino F, Yoshida K, Taguchi K, Todo S, Kohgo T, Totsuka Y, Shindoh M.
    Oncol Rep; 2005 Apr 01; 13(4):715-20. PubMed ID: 15756447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.